Mitochondrial Complex I Subunits Are Decreased in Murine Nonalcoholic Fatty Liver Disease: Implication of Peroxynitrite
Abstract
We investigate the cause of the low activity of mitochondrial complex I found in ob/ob mice with nonalcoholic fatty liver disease. In mitochondrial proteins from ob/ob mice, we assessed complex I activity, fully assembled complex I, and its subunits, oxygen consumption, gene expression of complex I subunits, and oxidative damage to DNA. In mitochondrial proteins from the liver of ob/ob mice, complex I activity, fully assembly of this complex and complex I subunits were markedly reduced. Likewise, gene expression of mitochondrial DNA-encoded subunits was significantly decreased in obese mice, but not nuclear DNA-encoded subunits. Treatment of obese mice with uric acid, anti-TNFalpha antibody or a mimic of manganese superoxide dismutase normalized all these abnormalities. "In vitro" addition of peroxynitrite to mitochondrial proteins from wild-type mice reproduced the abnormalities found in ob/ob mice (decreased complex I activity, the amount of fully assembled complex I, and its subunits, and mitochondrial oxygen consumption). Low activity of complex I found in ob/ob mice can be ascribed to a reduced amount of fully assembled complex, which may be attributed to degradation and reduced synthesis of its subunits by peroxynitrite. Exposure of mitochondrial proteins from normal mice to peroxynitrite reproduced the proteomic abnormalities present in ob/ob mice.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The pathogenesis of NAFLD comprises several other dynamic pathways and cross-talks between two or more cell types in the liver.
“The pathogenesis of NAFLD also comprises of several other dynamic pathways and cross-talks between two or more cell types in liver [47].”
From Intervention by picroside II on FFAs induced lipid accumulation and lipotoxicity in HepG2 cells (2021) · cites this paper as [47]
Cited by
Sorted by citations
Montfort, C. V., Matias, N., Fernandez, A., Fucho, R., de la Rosa, L. C., Martinez-Chantar, M. L., Mato, J. M., Machida, K., Tsukamoto, H., Murphy, M. P., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.024 · Cited by 83 · see citing works
García-Ruiz, I., Solís-Muñoz, P., Fernández-Moreira, D., Grau, M., Muñoz-Yagüe, M. T., & Solís-Herruzo, J. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-19973-z · Cited by 16 · see citing works
Self-citationIntervention by picroside II on FFAs induced lipid accumulation and lipotoxicity in HepG2 cells
Dhami-Shah, H., Vaidya, R., Talwadekar, M., Shaw, E., Udipi, S., Kolthur-Seetharam, U., & Vaidya, A. D. B. (2021) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2021.04.007 · Cited by 15 · see citing works
“The pathogenesis of NAFLD also comprises of several other dynamic pathways and cross-talks between two or more cell types in liver [47].”
Background
- Authors
- García-Ruiz, I., Fernández-Moreira, D., Solís-Muñoz, P., Rodríguez-Juan, C., Díaz-Sanjuán, T., Muñoz-Yagüe, T., & Solís-Herruzo, J. A.
- Affiliations
- Research Center, Laboratory of Gastroenterology and Hepatology, Hospital Universitario “12 de Octubre”, 28041 Madrid, Spain
- Research Institute Hospital 12 de Octubre (ES)
- Venue
- Journal of Proteome Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-03-29
- Volume
- 9
- Issue
- 5
- Pages
- 2450-2459
- ISSN
- 1535-3893 (ISSN-L)
- 1535-3907
- OpenAlex
- W2088821199
- Cited by
- 46
- References
- 0
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 2 · 2016: 3 · 2015: 2 · 2014: 7 · 2013: 3 · 2012: 4
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Proteome Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Keywords
- mitochondrial complex I, non-alcoholic fatty liver disease, ob/ob mice, peroxynitrite, oxidative damage, complex I assembly, mitochondrial oxygen consumption, uric acid, anti-TNF-alpha antibody, manganese superoxide dismutase, mitochondrial proteome, obesity
- MeSH terms
- Prohibitins, Animals, DNA Damage, DNA, Mitochondrial, Fatty Liver, Liver, Male, Metalloporphyrins, Mice, Inbred C57BL, Mice, Obese, Mice, Transgenic, Repressor Proteins, Oxidative Stress, Leptin, Peroxynitrous Acid, Electron Transport Complex I, Mitochondrial Membranes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review